News

Check out market updates

Longmont-made gene therapy significantly extends infant patient survival rate, new data says

BASEL, Switzerland and LONGMONT — Novartis AG (NYSE: NVS) said its treatment for spinal muscular atrophy, which is partially made […]
Source: BizWest

Leave a Reply

Your email address will not be published. Required fields are marked *

X